AIMV (AI Maverick Intel) ROCE %: 0.00% (As of Mar. 2011)


What is AI Maverick Intel ROCE %?

AI Maverick Intel AIMV ROCE % is 0.00% as of Mar. 2011.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. AI Maverick Intel's annualized ROCE % for the quarter that ended in Mar. 2011 was 0.00%.


AI Maverick Intel  (OTCPK:AIMV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


AI Maverick Intel ROCE % Related Terms


AI Maverick Intel ROCE % Historical Data

* Premium members only.

The historical data trend for AI Maverick Intel's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AI Maverick Intel ROCE % Chart

AI Maverick Intel Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
ROCE %
0.00 0.00 0.00 0.00 0.00

AI Maverick Intel Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AI Maverick Intel ROCE % Calculation

AI Maverick Intel's annualized ROCE % for the fiscal year that ended in Dec. 2010 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2010 )  (A: Dec. 2009 )(A: Dec. 2010 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2010 )  (A: Dec. 2009 )(A: Dec. 2010 )
=-3.885/( ( (0.472 - 1.891) + (1.33 - 2.201) )/ 2 )
=-3.885/( (-1.419+-0.871)/ 2 )
=-3.885/-1.145
=339.30 %

AI Maverick Intel's ROCE % of for the quarter that ended in Mar. 2011 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2011 )  (Q: Dec. 2010 )(Q: Mar. 2011 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2011 )  (Q: Dec. 2010 )(Q: Mar. 2011 )
=-22.692/( ( (1.33 - 2.201) + (0.647 - 2.127) )/ 2 )
=-22.692/( ( -0.871 + -1.48 )/ 2 )
=-22.692/-1.1755
=0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2011) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
AI Maverick Intel (AIMV) has a ROCE % of 0.00% as of Mar. 2011.
Is AI Maverick Intel's ROCE % too high?
AI Maverick Intel's current ROCE % is 0.00%.
How does AI Maverick Intel's ROCE % compare to DXTR and NURO?
AI Maverick Intel's ROCE % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AI Maverick Intel's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AI Maverick Intel stock overvalued right now?
AI Maverick Intel (AIMV) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For AI Maverick Intel (AIMV), the current ROCE % is 0.00% as of Mar. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AI Maverick Intel Business Description

Address 5480 Glen Erin Drive, Unit 105, Mississauga, ON, CAN, L5M 5R3
AI Maverick Intel Inc is an artificial intelligence company focused on revolutionizing customer acquisition and sales engagement through its platform. The company utilizes its proprietary "AI Maverick" platform to automate two-way communication and data-driven engagement, targeting industries such as healthcare, biotech, insurance, and transportation.